Cargando…
Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment
Hypertension is a leading risk factor for cardiovascular diseases and can reduce life expectancy. Owing to the widespread use of antihypertensive drugs, patients with hypertension have improved blood pressure control over the past few decades. However, for a considerable part of the population, thes...
Autores principales: | Chen, Hui-Qing, Gong, Jin-Yu, Xing, Kai, Liu, Mou-Ze, Ren, Huan, Luo, Jian-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808336/ https://www.ncbi.nlm.nih.gov/pubmed/35127738 http://dx.doi.org/10.3389/fmed.2021.742394 |
Ejemplares similares
-
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
por: Panebianco, Concetta, et al.
Publicado: (2018) -
Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
por: Luo, Jian-Quan, et al.
Publicado: (2023) -
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
por: Ting, Nick Lung-Ngai, et al.
Publicado: (2022) -
Pharmacomicrobiomics of Classical Immunosuppressant Drugs: A Systematic Review
por: Manes, Annalaura, et al.
Publicado: (2023) -
Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out
por: Conti, Gabriele, et al.
Publicado: (2022)